NEURO-DEGENERATIVE DISEASE
Clinical trials for NEURO-DEGENERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new NEURO-DEGENERATIVE DISEASE trials appear
Sign up with your email to follow new studies for NEURO-DEGENERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin e derivative tested as Parkinson's slowing agent in new trial
Disease control OngoingThis study tests whether a daily dose of tocotrienols (a type of vitamin E) can slow the worsening of motor symptoms in Parkinson's disease. One hundred adults with Parkinson's will take either the supplement or a placebo for two years. Researchers will track movement, thinking, …
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: PHASE2 • Sponsor: National Neuroscience Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Researchers track rare nerve disease to unlock future treatments
Knowledge-focused OngoingThis study follows 20 people with a rare nerve disease called CMT4J for up to 2 years. Researchers will track symptoms and health changes to better understand how the disease progresses. The goal is to find better ways to measure the disease, which could help design future treatm…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Sponsor: Elpida Therapeutics SPC • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC